Sign in

    Randall C. Stuewe

    Chairman of the Board and Chief Executive Officer at Darling Ingredients Inc
    Board
    Since February 2003
    Age
    62 years
    Tenure
    Has served as Chairman of the Board and Chief Executive Officer since February 2003.

    Also at Darling Ingredients Inc

    SD
    Sandra Dudley
    Executive Vice President – Renewables and Chief Strategy Officer
    BL
    Brandon Lairmore
    Executive Vice President – Darling U.S. Rendering Operations
    CP
    Carlos Paz
    Executive Vice President, Global Risk Management, Ingredients

    About

    Randall C. Stuewe, born in 1963 and currently 62 years old as of March 20, 2025 , brings decades of experience to his leadership role.

    With over 35 years in the agriculture processing industry, he built his career through roles at major companies such as Cargill, Incorporated and ConAgra Foods, Inc. where he served as Executive Vice President and later President of Gilroy Foods.

    Since joining DAR in February 2003, he has led the company as its Chairman of the Board and Chief Executive Officer, guiding strategic direction and operational excellence.

    Additionally, his role as director and chair of the compensation committee at Teays River Investments LLC highlights his broader influence in the agribusiness sector, reinforcing his reputation as a well-rounded and experienced leader.

    $DAR Performance Under Randall C. Stuewe

    Past Roles

    OrganizationRoleDate RangeDetails
    ConAgra Foods, Inc. Executive Vice President and later President of Gilroy Foods 1996 to 2002 Role advanced from EVP to President
    Cargill, Incorporated Various management, sales, and trading positions Pre-1996 (spanning 12 years) Held multiple positions before joining ConAgra

    External Roles

    OrganizationRoleDate RangeDetails
    Teays River Investments LLC Director and Chair of the Compensation Committee N/A N/A

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary $1,260,000 Annually for 2024Fixed base annual salary for fiscal year 2024
    Health and Welfare Benefits $75,032 Lump sum; continues for 2 years post terminationEstimated lump sum present value of future health and dental insurance premiums
    Life Insurance Benefits $4,350,000 Payable upon deathIncludes 1x base salary capped at $350,000 plus 4x base salary capped at $4,000,000
    Option Awards [N/A]NoneN/ANo option awards specified for 2024 [N/A]
    All Other Compensation $95,757 AnnuallyFixed additional compensation component
    Termination Payments (Without Cause/Resignation for Good Reason) Compensation: $2,520,000; Annual Incentive Bonus: $608,580; Equity Awards: $3,776,162 Payable upon terminationCompensation breakdown if terminated without cause or for resignation for good reason
    Termination Payments (Following Change of Control) Compensation: $3,780,000; Annual Incentive Bonus: $608,580; Health and Welfare Benefits: $109,597; Equity Awards: $7,119,686 Payable upon termination following change of controlDetailed breakdown provided for termination following a change of control

    Performance Compensation

    Data from  FY 2024

    Annual Incentive Bonus

    MetricValueDetails
    Weighting - Adjusted EBITDA65%Global adjusted EBITDA metric; no payout achieved as the performance was below the threshold
    Weighting - SOPs35%Achievement of Strategic, Operational, and Personal goals; Mr. Stuewe earned 32% of his target bonus opportunity for SOPs
    Threshold$968,625Minimum performance level required
    Target$1,890,000Target bonus opportunity
    Maximum$3,780,000Cap on bonus payout assuming 200% achievement of SOPs
    Performance PeriodDec 31, 2023 - Dec 28, 2024Defined evaluation period
    Grant DateJan 3, 2024Approved on Dec 15, 2023
    VestingN/ACash award; no vesting schedule since payout is based on fiscal year performance

    Non-Equity Incentive Plan Compensation

    MetricValueDetails
    Weighting - Adjusted EBITDA65%Performance measured globally; 65% component tied to adjusted EBITDA
    Weighting - SOPs35%35% component tied to achieving strategic, operational, and personal objectives
    Threshold$968,625Minimum performance requirement
    Target$1,890,000Target bonus level
    Maximum$3,780,000Maximum payout at 200% achievement of performance goals
    Performance PeriodDec 31, 2023 - Dec 28, 2024Evaluation period for performance
    Grant DateJan 3, 2024Approved on Dec 15, 2023
    VestingN/ACash-based plan; no vesting schedule

    Stock Awards

    MetricValueDetails
    Performance MetricsROGI and TSRBased on Relative Return on Gross Investment and Total Shareholder Return
    Threshold0 PSUsMinimum payout is zero
    Target72,685 PSUsTarget number of Performance Stock Units (PSUs)
    Maximum163,541 PSUsMaximum number of PSUs
    Performance PeriodDec 31, 2023 - Jan 2, 2027Evaluation period spans over multiple years
    Vesting Schedule1/3 annuallyRSUs vest in one-third annual increments on each anniversary of the grant date
    Grant DateJan 3, 2024Approved on Dec 15, 2023
    Grant Date Fair Value$6,258,389Fair value of the awarded stock
    Grant Date Stock Price$33.46Closing price per share as of Dec 27, 2024
    RSUs Awarded48,456 RSUsNumber of Restricted Stock Units awarded
    Target LTI Value$5,937,120Increased target long-term incentive value equal to 471.2% of base salary

    These tables summarize the performance compensation components, including required performance metrics, payout thresholds, targets, caps, and other key details for 2024.